(3AR,3A'R,8AS,8A'S)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(3A,8A-二氢-8H-茚并[1,2-D]恶唑) (3aR,3a'R,8aS,8a'S)-2,2'-(1,3-Bis(4-(adamantan-1-yl)phenyl)propane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
-
(3aR,3a'R,8aS,8a'S)-2,2'-(1,3-二苯基丙烷-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]噁唑) (3aR,3a'R,8aS,8a'S)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
R104620-25mg | 25mg
-
(3aR,3a'R,8aS,8a'S)-2,2'-(1,3-二苯基丙烷-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]噁唑) (3aR,3a'R,8aS,8a'S)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
R104620-100mg | 100mg
-
(3AR,3A'R,8AS,8A'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)BIS[3A,8A-二氢-8H-茚满[1,2-D]噁唑 (3aR,3a'R,8aS,8a'S)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
V82719-250mg | 250mg
-
(3AR,3A'R,8AS,8A'S)-2,2'-(1-苯基丙烷-2,2-二基)双(8,8A-二氢-3AH-茚并[1,2-D]恶唑) (3AR,3a'R,8aS,8a'S)-2,2'-(1-phenylpropane-2,2-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole)
V82730-250mg | 250mg
-
(3AS,3A'S,8AR,8A'R)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(3A,8A-二氢-8H-茚并[1,2-D]恶唑) (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Bis(4-(adamantan-1-yl)phenyl)propane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
V82864-250mg | 250mg
-
(3aS,3a'S,8aR,8a'R)-2,2'-(2,3-二氢-1H-茚-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]恶唑) (3aS,3a''S,8aR,8a''R)-2,2''-(1,3-Dihydro-2H-inden-2-ylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
S54345-100mg | 100mg
-
(3aS,3a'S,8aR,8a'R)-2,2'-(1,3-双(4-(叔丁基)苯基)丙烷-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]恶唑) (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Bis(4-(tert-butyl)phenyl)propane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)(97%)
V14602-250mg | 250mg
分子式:C55H58N2O2
分子量:779.06
储存条件:RT,惰性气体
外观:White to off-white Solid
用途:
您正在浏览的产品:(3AR,3A'R,8AS,8A'S)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(3A,8A-二氢-8H-茚并[1,2-D]恶唑)
本公司销售的所有产品仅供实验科研使用,不用于人体及临床诊断。